Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Six

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Antimicrobial Agents and Chemotherapy|September 12, 2025
<i>Burkholderia pseudomallei</i> PenI β-lactamase and variants are potently inhibited by taniborbactamMaria F Mojica, Scott A Becka, Mitchell Edwards, et al.
The Journal of Biological Chemistry|February 1, 2022
Fluorescent sensors of siderophores produced by bacterial pathogensAshish Kumar, Taihao Yang, Somnath Chakravorty, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosaJodie C Hamrick, Jean-Denis Docquier, Tsuyoshi Uehara, et al.
Journal of Lipid Research|July 31, 2010
Lipidomics reveals a remarkable diversity of lipids in human plasmaOswald Quehenberger, Aaron M Armando, Alex H Brown, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Antimicrobial Agents and Chemotherapy|September 12, 2025
<i>Burkholderia pseudomallei</i> PenI β-lactamase and variants are potently inhibited by taniborbactamMaria F Mojica, Scott A Becka, Mitchell Edwards, et al.
The Journal of Biological Chemistry|February 1, 2022
Fluorescent sensors of siderophores produced by bacterial pathogensAshish Kumar, Taihao Yang, Somnath Chakravorty, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosaJodie C Hamrick, Jean-Denis Docquier, Tsuyoshi Uehara, et al.
Journal of Lipid Research|July 31, 2010
Lipidomics reveals a remarkable diversity of lipids in human plasmaOswald Quehenberger, Aaron M Armando, Alex H Brown, et al.
Pageof 9